Mouna Attarha News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Trial First to Show Improvements in Alzheimer s Patients News provided by Share this article Share this article BURLINGAME, Calif., May 13, 2021 /PRNewswire/ Pharmaceutical trials for Alzheimer s have failed repeatedly, but a new study, using a fundamentally different approach, has provided the first success: using precision medicine to identify and target the drivers of Alzheimer s or pre-Alzheimer s in each patient, a team of physicians and researchers has posted exciting, positive results in medRxiv, the Yale-backed site for health sciences. (PRNewsfoto/Apollo Health) (PRNewsfoto/Apollo Health) Until now, therapeutic development for Alzheimer s disease has been almost uniformly unsuccessful, with over 400 failed clinical trials. The few successes (e.g., memantine) have not offered sustained improvement. For example, the recent claim of a positive trial for the drug candidate donanemab did not show cognitive improvement, nor even stabilization of dementia, but merely red

Kat toupsJong chwaDale bredesenAnn hathawayCyrus rajiDeborah gordonSharon hausman cohenMouna attarhaMichael jarrettBenjamin hillAlan boydHenrianna chungQuesgen systems incWinds foundationApollo healthPrecision medicine approach